Impact of gene patents on diagnostic testing: A new patent landscaping method applied to spinocerebellar ataxia

European Journal of Human Genetics

Volumn 19, Issue 11, 2011, Pages 1114-1121

  Berthels, Nele ^a   Matthijs, Gert ^a,b   Van Overwalle, Geertrui ^a,b  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b TILBURG UNIVERSITY   (Netherlands)

Author keywords

gene patents; genetic testing; patent licensing; spinocerebellar ataxia

Indexed keywords

ARTICLE; DIAGNOSTIC TEST; DISEASE ASSOCIATION; DNA DETERMINATION; GENE; GENETIC HETEROGENEITY; GENETIC SCREENING; HUMAN; PRIORITY JOURNAL; SPINOCEREBELLAR ATAXIA GENE; SPINOCEREBELLAR DEGENERATION;

EUROPE; GENETIC TESTING; HUMANS; LICENSURE; PATENTS AS TOPIC; SPINOCEREBELLAR ATAXIAS; UNITED STATES;

EID: 80054809539     PISSN: 10184813     EISSN: 14765438     Source Type: Journal    
DOI: 10.1038/ejhg.2011.109     Document Type: Article

References (35)

1. Cook-Deegan R, Chandrasekharan S, Angrist M: The dangers of diagnostic monopolies. Nature 2009; 458: 405-406.
2. Also see the case studies carried out by Cook-Deegan and his team: Patently Complicated: Case studies on the impact of patenting and licensing on clinical access to genetic testing in the United States. Genet Med 2010; 12(4 suppl): S1-S211
3. Gaisser S, Hopkins MM, Liddell K, Zika E, Ibarreta D: The phantom menace of gene patents. Nature 2009; 458: 407-408
4. Kaye J, Hawkins N, Taylor J: Patents and translational research in genomics. Nat Biotechnol 2007; 25: 739-741 (Pubitemid 47053866)
5. Klein RD: Gene patents and genetic testing in the United States. Nat Biotechnol 2007; 25: 989-990 (Pubitemid 47517633)
6. Cho MK, Illangasekare S, Weaver MA, Leonard DG, Merz JF: Effects of patents and licenses on the provision of clinical genetic testing services. J Mol Diagn 2003; 5: 3-8 (Pubitemid 36192993)
7. Matthijs G: The European opposition against the BRCA gene patents. Fam Cancer 2006; 5: 95-102 (Pubitemid 43384324)
8. Matthijs G, Halley D: European-wide opposition against the breast cancer gene patents. Eur J Hum Genet 2002; 10: 783-785
9. SACGHS: Gene Patents and Licensing Practices and Their Impact on Patient Access to Genetic Tests. SACGHS, NIH: Bethesda, MD, April 2010. Available at http:// oba.od.nih.gov/oba/sacghs/reports/SACGHS-patents-report-2010.pdf
10. Ibarreta D, Elles R, Cassiman JJ, Rodriguez-Cerezo E, Dequeker E: Towards quality assurance and harmonization of genetic testing services in the European Union. Nat Biotechnol 2004; 22: 1230-1235 (Pubitemid 39336771)
11. Barton JH: Emerging patent issues in genomic diagnostics. Nat Biotechnol 2006; 24: 939-941
12. Cassiman JJ: Research network: EuroGentest- a European Network of Excellence aimed at harmonizing genetic testing services. Eur J Hum Genet 2005; 13: 1103-1105
13. ACMG (American College of Medical Genetics): Standards and guidelines for clinical genetics laboratories 2007 edition. Available at http://www.acmg.net
14. Hopkins MM, Mahdi S, Patel P, Thomas SM: DNA patenting: The end of an era? Nat Biotechnol 2007; 25: 185-187 (Pubitemid 46227114)
15. Jensen K, Murray F: Intellectual property landscape of the human genome. Science 2005; 310: 239-240 (Pubitemid 41457177)
16. Article 28 (1) Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPs Agreement), 1994 (http://www.wto.org/english/docs-e/ legal-e/27-trips.pdf)
17. Schöls L, Bauer P, Schmidt T, Schulte T, Riess O: Autosomal dominant cerebellar ataxias: clinical features, genetics, and pathogenesis. Lancet Neurol 2004; 3: 291-304 (Pubitemid 38510200)
18. Edlefsen KL, Tait JF, Wener MH, Astion M: Utilization and diagnostic yield of neurogenetic testing at a tertiary care facility. Clin Chem 2007; 53: 1016-1022 (Pubitemid 46867516)
19. Verbeure B, Matthijs G, Van Overwalle G: Analysing DNA patents in relation with diagnostic genetic testing. Eur J Hum Genet 2006; 14: 26-33 (Pubitemid 43019080)
20. Huys I, Berthels N, Matthijs G, Van Overwalle G: Legal uncertainty in the area of genetic diagnostic testing. Nat Biotechnol 2009; 27: 903-909
21. Bird WE: Using the EPO opposition procedure as a strategy against patents on diagnostic methods; In: Van Overwalle (ed): Gene patents and Public Health. Brussels: Belgium, Bruylant, 2007; pp 75-78
22. Riess O, Schöls L, Bottger H et al: SCA6 is caused by moderate CAG expansion in the alpha1A-voltage-dependent calcium channel gene. Hum Mol Genet 1997; 6: 1289-1293 (Pubitemid 27351069)
23. Van Overwalle G, van Zimmeren E, Verbeure B, Matthijs G: Models for facilitating access to patents on genetic inventions. Nat Rev Genet 2006; 7: 143-148 (Pubitemid 43128899)
24. Merges R: Contracting into liability rules: Intellectual property rights and collective rights organizations. Calif Law Rev 1996; 84: 1293-1293
25. Shapiro C: Navigating the patent thicket: Cross licenses, patent pools and standard setting; In Jaffe E, Lerner J, Stern S (eds): Innovation Policy and the Economy, (vol. 1.), Cambridge, MA: MIT Press, 2001, pp 119-150. Available at http://faculty.- haas.berkeley.edu/shapiro/thicket.pdf
26. Ebersole T, Guthrie M, Goldstein JA: Patent pools as a solution to the licensing problems of diagnostic genetics. IP Techn Law J 2005; 17: 1-8
27. OECD: Guidelines for the licensing of genetic inventions. Available at www.oecd.org/sti/ biotechnology/licensing
28. European Society of Human Genetics: Recommendations on patenting and licensing in genetic testing. Eur J Hum Genet 2008; 16: 405-411
29. Azzazy H, Mansour M, Kazmierczak S: Nanodiagnostics: A new frontier for clinical laboratory medicine. Clin Chem 2006; 52: 1238-1246 (Pubitemid 43956012)
30. Modoni A, Contarino MF, Bentivoglio AR et al: Prevalence of spinocerebellar ataxia type 2 mutation among Italian Parkinsonian patients. Mov Disord 2007; 22: 324-327 (Pubitemid 46569684)
31. Elden AC, Kim H-J, Hart MP et al: Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS. Nature 2010; 466: 1069-1075
32. Macpherson J, Waghorn A, Hammans S, Jacobs P: Observation of an excess of fragile-X premutations in a population of males referred with spinocerebellar ataxia. Hum Genet 2003; 112: 619-620 (Pubitemid 36869058)
33. Schneider SA, Walker RH, Bhatia KP: The Huntingtons disease-like syndromes: What to consider in patients with a negative Huntingtons disease gene test. Nat Clin Pract 2007; 3: 517-525 (Pubitemid 47377611)
34. Van Overwalle G (ed): Gene Patents and Collaborative Licensing Models. Patent Pools, Clearinghouses, Open Source Models and Liability Regimes. Cambridge: Cambridge University Press, 2009
35. Van Zimmeren E, Van Overwalle G: A Paper Tiger? Compulsory License Regimes for Public Health in Europe. International Review of Intellectual Property and Competition Law (IIC) 2011, 4-40